Delivery Order SPE2DB20D1109-SPE2DB25FP68T
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for $1,416.30 to supply ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 14, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 ml syringes, a pediatric hepatitis B vaccine. This firm fixed-price delivery order, valued at $3,057.06, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract is scheduled for completion by September 15, 2025, with performance taking place at...
- The Defense Logistics Agency awarded a $1,852.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B PEDI 10 MCG/0.5 ML syringes, a pediatric hepatitis B vaccine. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a routine pharmaceutical procurement under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,447.26 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRINGE 0.5ML, a pediatric hepatitis B vaccine product. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,830.31 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product. The contract, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement for vaccine supplies to...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $5,233.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B PEDI 10 MCG/0.5 syringe in 0.5 milliliter units. This pediatric hepatitis B vaccine delivery order was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside transaction issued under an existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,124.45 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 ml syringes on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in pediatric immunization...
- The Defense Logistics Agency awarded a $12,635.85 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine product. This competitive award, issued without set-aside designation, is classified as a firm fixed price delivery order with an ultimate completion date of September 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...